Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -67,846 | -39,023 | -154,154 | -125,170 | -114,446 |
| Depreciation Amortization | 5,640 | 2,328 | 11,107 | 8,890 | 6,533 |
| Accounts receivable | 4,605 | 5,417 | 12,551 | 19,727 | 10,897 |
| Other Working Capital | 3,182 | 5,665 | -12,519 | 5,634 | 13,897 |
| Other Operating Activity | 7,194 | 226 | 14,790 | -2,371 | 6,608 |
| Operating Cash Flow | $-47,225 | $-25,387 | $-128,225 | $-93,290 | $-76,511 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 2,902 | 2,965 | -2,034 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -5,000 |
| Purchase Sale Intangibles | N/A | N/A | -5,000 | -5,000 | N/A |
| Other Investing Activity | 0 | 0 | -5,005 | -5,005 | -5 |
| Investing Cash Flow | $N/A | $N/A | $-2,103 | $-2,040 | $-7,039 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 28,000 | N/A | N/A |
| Debt Issued | 5,000 | N/A | 14,529 | 27,909 | 27,910 |
| Debt Repayment | N/A | N/A | -50,375 | -50,375 | -40,375 |
| Common Stock Issued | 26,769 | 10,282 | 24,800 | 13,450 | 38,962 |
| Dividend Paid | -352 | -2,184 | -8,768 | -6,580 | -4,387 |
| Other Financing Activity | 10,707 | 19,761 | 24,553 | 4,717 | -30,304 |
| Financing Cash Flow | $42,124 | $27,859 | $32,739 | $-10,879 | $-8,194 |
| Beginning Cash Position | 83,365 | 83,365 | 180,954 | 180,954 | 180,954 |
| End Cash Position | 78,264 | 85,837 | 83,365 | 74,745 | 89,210 |
| Net Cash Flow | $-5,101 | $2,472 | $-97,589 | $-106,209 | $-91,744 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,225 | -25,387 | -128,225 | -93,290 | -76,511 |
| Capital Expenditure | N/A | N/A | -3,098 | -3,035 | -2,034 |
| Free Cash Flow | -47,225 | -25,387 | -131,323 | -96,325 | -78,545 |